Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-569
Closed -$68.4K 179
2026
Q1
$68.4K Buy
569
+5
+0.9% +$577 0.03% 97
2025
Q4
$59.4K Buy
564
+5
+0.9% +$469 0.03% 94
2025
Q3
$46.9K Buy
559
+5
+0.9% +$412 0.02% 101
2025
Q2
$43.8K Buy
+554
New +$44K 0.02% 97
2024
Q1
Sell
-530
Closed -$57.8K 145
2023
Q4
$57.8K Buy
530
+4
+0.8% +$415 0.04% 62
2023
Q3
$54.6K Buy
+526
New +$56.7K 0.05% 60

Other funds holding MRK

Team Financial Group's MRK Position: Q2 2026 in Review

Team Financial Group sold out of Merck (MRK) in Q2 2026, closing a stake of 569 shares — an estimated $68.4K sold.

Team Financial Group first reported a position in MRK in Q3 2023 and held it in 6 quarters. The position peaked at $68.4K in Q1 2026. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Team Financial Group reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Team Financial Group sold 569 Merck shares in Q2 2026, an estimated $68.4K.
  • Team Financial Group first reported a position in Merck in Q3 2023 and held it in 6 quarters.
  • Team Financial Group's Merck position peaked at $68.4K in Q1 2026.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Team Financial Group's 13F filing for Q2 2026, filed 13 Jul 2026.